|
RAB2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.836200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.509780E-01 |
| Normal-vs-Stage2 |
1.763030E-01 |
| Normal-vs-Stage3 |
1.389620E-01 |
| Normal-vs-Stage4 |
7.575800E-01 |
| Stage1-vs-Stage2 |
7.766000E-01 |
| Stage1-vs-Stage3 |
7.291800E-01 |
| Stage1-vs-Stage4 |
3.421200E-01 |
| Stage2-vs-Stage3 |
9.637600E-01 |
| Stage2-vs-Stage4 |
2.054000E-01 |
| Stage3-vs-Stage4 |
1.696830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.853700E-02 |
| Normal-vs-AfricanAmerican |
1.674570E-01 |
| Normal-vs-Asian |
6.883800E-01 |
| Caucasian-vs-AfricanAmerican |
9.826400E-01 |
| Caucasian-vs-Asian |
7.230600E-01 |
| AfricanAmerican-vs-Asian |
7.159800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.010350E-01 |
| Normal-vs-Female |
1.442220E-01 |
| Male-vs-Female |
8.141400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.555600E-01 |
| Normal-vs-Extreme_Weight |
1.908570E-01 |
| Normal-vs-Obese |
3.997700E-02 |
| Normal-vs-Extreme_Obese |
5.319800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.828800E-01 |
| Normal_Weight-vs-Obese |
2.389400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.325400E-01 |
| Extreme_Weight-vs-Obese |
3.843200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.851400E-01 |
| Obese-vs-Extreme_Obese |
5.513600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.433780E-01 |
| Normal-vs-Age(41-60Yrs) |
2.037400E-03 |
| Normal-vs-Age(61-80Yrs) |
5.543200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.564400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.145400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.516600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.088400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.195180E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.930100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.567800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.024500E-03 |
| Normal-VS-Type2 PRCC |
7.677200E-01 |
| Normal-VS-KIRP CIMP |
5.229800E-01 |
| Normal-VS-Unclassified PRCC |
2.050200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.48330000000619E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.721200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.171400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.238200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.135190E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.236400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.245200E-01 |
| Normal-vs-N1 |
8.207600E-02 |
| Normal-vs-N2 |
7.661900E-02 |
| N0-vs-N1 |
1.746180E-01 |
| N0-vs-N2 |
5.540400E-02 |
| N1-vs-N2 |
6.380900E-03 |
|
|
